Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathew Vithayathil

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
NPJ Precision Oncology|February 11, 2026
Itacitinib in advanced hepatocellular cancer following first line therapyAlessandro Troiani, Lingshan Hung, David J Pinato, et al.
Endoscopy|January 19, 2023
The effect of procedural time on dysplasia detection rate during endoscopic surveillance of Barrett's esophagusMathew Vithayathil, Ines Modolell, Jacobo Ortiz-Fernandez-Sordo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 20, 2022
Image-Enhanced Endoscopy and Molecular Biomarkers Vs Seattle Protocol to Diagnose Dysplasia in Barrett's EsophagusMathew Vithayathil, Ines Modolell, Jacobo Ortiz-Fernandez-Sordo, et al.
Cancers|August 10, 2024
Prospective Study of Non-Contrast, Abbreviated MRI for Hepatocellular Carcinoma Surveillance in Patients with Suboptimal Hepatic Visualisation on UltrasoundMathew Vithayathil, Maria Qurashi, Pedro Rente Vicente, et al.
Cancers|July 14, 2023
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort StudyShuell De Souza, Jeffrey Kahol de Jong, Ylenia Perone, et al.
Langenbeck'S Archives of Surgery|September 13, 2024
The role of resection in hepatocellular carcinoma BCLC stage B: A multi-institutional patient-level meta-analysis and systematic reviewVictor Lopez-Lopez, Fabian Kalt, Jian-Hong Zhong, et al.
Langenbeck'S Archives of Surgery|October 25, 2024
Correction to: The role of resection in hepatocellular carcinoma BCLC stage B: A multi-institutional patient-level meta-analysis and systematic reviewVictor Lopez-Lopez, Fabian Kalt, Jian-Hong Zhong, et al.
Hepatology International|April 3, 2023
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinomaMathew Vithayathil, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 20, 2022
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinomaMathew Vithayathil, Antonio D'Alessio, Claudia A M Fulgenzi, et al.
Nature Reviews. Gastroenterology & Hepatology|December 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and prioritiesJesus M Banales, Pedro M Rodrigues, Silvia Affò, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
NPJ Precision Oncology|February 11, 2026
Itacitinib in advanced hepatocellular cancer following first line therapyAlessandro Troiani, Lingshan Hung, David J Pinato, et al.
Endoscopy|January 19, 2023
The effect of procedural time on dysplasia detection rate during endoscopic surveillance of Barrett's esophagusMathew Vithayathil, Ines Modolell, Jacobo Ortiz-Fernandez-Sordo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 20, 2022
Image-Enhanced Endoscopy and Molecular Biomarkers Vs Seattle Protocol to Diagnose Dysplasia in Barrett's EsophagusMathew Vithayathil, Ines Modolell, Jacobo Ortiz-Fernandez-Sordo, et al.
Cancers|August 10, 2024
Prospective Study of Non-Contrast, Abbreviated MRI for Hepatocellular Carcinoma Surveillance in Patients with Suboptimal Hepatic Visualisation on UltrasoundMathew Vithayathil, Maria Qurashi, Pedro Rente Vicente, et al.
Cancers|July 14, 2023
Impact of COVID-19 on 1-Year Survival Outcomes in Hepatocellular Carcinoma: A Multicenter Cohort StudyShuell De Souza, Jeffrey Kahol de Jong, Ylenia Perone, et al.
Langenbeck'S Archives of Surgery|September 13, 2024
The role of resection in hepatocellular carcinoma BCLC stage B: A multi-institutional patient-level meta-analysis and systematic reviewVictor Lopez-Lopez, Fabian Kalt, Jian-Hong Zhong, et al.
Langenbeck'S Archives of Surgery|October 25, 2024
Correction to: The role of resection in hepatocellular carcinoma BCLC stage B: A multi-institutional patient-level meta-analysis and systematic reviewVictor Lopez-Lopez, Fabian Kalt, Jian-Hong Zhong, et al.
Hepatology International|April 3, 2023
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinomaMathew Vithayathil, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 20, 2022
Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinomaMathew Vithayathil, Antonio D'Alessio, Claudia A M Fulgenzi, et al.
Nature Reviews. Gastroenterology & Hepatology|December 10, 2025
Cholangiocarcinoma 2026: status quo, unmet needs and prioritiesJesus M Banales, Pedro M Rodrigues, Silvia Affò, et al.
Pageof 6